Thomas M. Stepien, who serves as both Chief Executive Officer and a director of Amprius Technologies, Inc. (NASDAQ:AMPX), sold 4,375 shares of the company's common stock on May 27, 2026. The total proceeds from this transaction amounted to $75,221.
The sale was executed at varying prices for each share, ranging between $17.13 and $17.3 per unit. According to the filing details, this specific stock disposition was classified as a "sell-to-cover" arrangement. This mechanism is mandated by the issuer and was utilized specifically to fund tax withholding obligations associated with the vesting of restricted stock units.
It is notable that since the time of this sale, the value of Amprius Technologies common stock has appreciated significantly, reaching $20.95 per share. This price movement reflects a substantial 600% return observed over the course of the preceding year.
Current Holdings and Valuation Context
Following the May 27th transaction, Mr. Stepien's direct holdings in Amprius Technologies common stock total 694,923 shares. This figure encompasses both his directly held units and 615,625 restricted stock units (RSUs). These RSUs represent a contingent entitlement to receive one share of common stock for every unit, subject to specific vesting schedules and associated conditions.
From an analytical perspective, the current valuation warrants attention. Analysis provided by InvestingPro indicates that the stock currently appears overvalued when compared against its calculated Fair Value, suggesting it may be categorized among companies placed on a 'Most Overvalued' list.
Recent Corporate and Operational Updates
In other recent corporate news, Amprius Technologies released its first-quarter 2026 earnings report. The financial results disclosed a net loss of $5 million, which equates to -$0.04 per share. This reported net loss was below the analyst expectation of -$0.0278 per share.
Despite reporting an earnings miss for the quarter, the company successfully surpassed expectations regarding its revenue generation. Amprius Technologies posted total revenues of $28.5 million, exceeding the forecasted amount of $25.32 million. In addition to these financial metrics, the firm announced a strategic collaboration with Matternet.
Under the terms of this partnership, Amprius Technologies will supply silicon anode lithium-ion batteries specifically designed for Matternet’s M2 delivery drones. The core objective of this alliance is to develop advanced battery solutions tailored for Matternet’s next-generation platform. Furthermore, the plans include moving toward volume production readiness in alignment with Matternet's projected fleet expansion, a timeline set for early 2027.
Market Scrutiny and Investor Attention
These developments have generated considerable interest among both investors and financial analysts. However, the company also faced heightened scrutiny following a detailed report issued by short seller Manatee Research. This report alleged irregularities concerning exaggerated orders and issues with disclosure practices. The investigation conducted as part of this review included interviews with various battery experts and physical site visits, thereby raising specific concerns regarding Amprius's operational integrity.
Risks
- The stock is flagged as potentially overvalued relative to its Fair Value by InvestingPro analysis.
- The company faced allegations from short seller Manatee Research regarding exaggerated orders and disclosure irregularities, raising operational concerns.
- The Q1 2026 net loss of $5 million was worse than the expected -$0.0278 per share.
More from Insider Trading